Ultragenyx

RARE · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reports earnings in about 1 month

Previous year: -$1.39

-7.2%

Total Operating Expenses

$321M

Previous year: $287M

+11.8%

Research and Development

$203M

Previous year: $188M

+8.0%

Selling, General and Administrative

Loading...

Ultragenyx

Unlock previous datapoints

Upgrade

Ultragenyx

Unlock previous datapoints

Upgrade

Ultragenyx Revenue by Segment

Ultragenyx Revenue by Geographic Location

Revenue by Segment

Crysvita Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Dojolvi Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Evkeeza Revenue

CapyFin.com

Mepsevii Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Revenue by Geographic Location

Product sales - Latin America and Türkiye Revenue

CapyFin.com

Royalty revenue - U.S. and Canada Revenue

CapyFin.com

Royalty revenue - Europe Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$1.87B

P/E Ratio

-3.56

Sector

N/A

Industry

N/A

52-Week High

$41.4

52-Week Low

$18.5

Total Operating Expenses

$321M

Research and Development

$203M

Selling, General and Administrative

$89M

Non-cash Stock Based Compensation

$38M

Net Cash Used in Operations

$100M

Products

Get in Touch

Resources

Ultragenyx

Ultragenyx

Ultragenyx

Ultragenyx Revenue by Segment

Ultragenyx Revenue by Geographic Location

Revenue by Segment

Crysvita Revenue

Dojolvi Revenue

Evkeeza Revenue

Mepsevii Revenue

Revenue by Geographic Location

Product sales - Latin America and Türkiye Revenue

Royalty revenue - U.S. and Canada Revenue

Royalty revenue - Europe Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics